chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient reports to Urgent Care today, 12/15/21 after covid-19 booster (3rd shot) given on 11/29/21 and symptoms of left shoulder pain occurred since 11/30/21. Likely shoulder rotator cuff tendinopathy as a result of his covid-19 vaccination given too superiorly on his left arm and subsequently into his shoulder joint. Patient says the shot was "way too high" and was scared it would be a problem. We will start with NSAID therapy, ice packs as tolerated. May need shoulder steroid injection vs physical therapy in near future.
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On an unknown dates, the patients received improperly stored (Oka/Merck) VARIVAX (lot# L017145, expiration date: 13-MAY-2017; lot # K026387, expiration date: 15-DEC-2016; lot# L006383, expiration date: 25-FEB-2017), 0.5 ml subcutaneously. No adverse effects reported. Additional information has been requested.
Pt recvd 3rd in a series of Engerix-B & exp titers of less than 10;
No additional AEs.; expired vaccine given to a patient; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 01-FEB-2021, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot # S021732 has been verified to be a valid lot number, albumin status has been verified as recombinant human albumin (rHA), expiration date reported as 10-JAN-2021 (formulation, strength, dose, frequency and route of administration were not reported) for prophylaxis. On 01-FEB-2021, the patient experienced expired product administered. On an unknown date the patient experienced no adverse event. The outcome of expired product administered and no adverse event was unknown. This agent confirmed there was no previous temperature excursion. Causality assessment was not provided.
Burning sensation in stomach, Chest pain, headache, dizzy/lightheaded, needle feeling in inner arm (the day of). Body soreness, fatigue, weak, chest pain, cough (day after). (On 2/13/21) still a headache with difficulty focusing vision, chest pains, shortness of breathe.
Kidney stones; This spontaneous case was reported by a consumer and describes the occurrence of NEPHROLITHIASIS (Kidney stones) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NEPHROLITHIASIS (Kidney stones) (seriousness criterion medically significant). At the time of the report, NEPHROLITHIASIS (Kidney stones) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.  The patient stated that another woman had a kidney stone after receiving the Moderna vaccine. There was another woman that had that a week before that. She knows of 5 total people who had kidney stones from the Moderna.  Company comment: This spontaneous case concerns a female patient of unknown age with no relevant medical history reported, who experienced serious unexpected event of nephrolithiasis. The event occurred unspecified time after the unspecified dose of the Moderna COVID-19 vaccine . Rechallenge was not applicable since due to unknown outcome and lack of information on the number of doses administered, no rechallenge was done and recurrence was not applicable.  The benefit-risk relationship of drug is not affected by this report.; Sender's Comments: This spontaneous case concerns a female patient of unknown age with no relevant medical history reported, who experienced serious unexpected event of nephrolithiasis. The event occurred unspecified time after the unspecified dose of the Moderna COVID-19 vaccine . Rechallenge was not applicable since due to unknown outcome and lack of information on the number of doses administered, no rechallenge was done and recurrence was not applicable.  The benefit-risk relationship of drug is not affected by this report.
Vaccine administered around 10:45(am) on 12/21/2020. Around 23:00(pm) (12/21/2020) I was feeling chilly, put my jacket while at work (night shift) on but continued to feel tired, eyes hurt a little, slight headache, general muscle soreness, and increasing pain in my left arm where I got the shot. I took 600mg Advil, felt fine most the night but still really tired. End of shift (07:30(am)) I was very tired with symptoms returning. Got home (08:00 on 12/22/2020), went right to sleep but at that point had chills, felt cold, headache, body aches, pain in left arm worse / really hurting - tender to touch but not swollen or red, neck glands ?felt swollen? but I don't think they actually were swollen. I woke up 4 hours later (12:00 - 12/22/2020) around noon exactly sweating, with all the same symptoms. No GI discomfort. I took 975mg Tylenol. Checked my temp, 99.9F. I couldn't fall back asleep for several hours and my body temperature felt like it was all over the place (sweating and hot, then cold, repeat). Finally fell asleep again from 16:00 to 21:30. Symptoms were all still present. Took Tylenol 1,000mg and stayed up until 05:00 (12/23/2020) with good relief from the Tylenol throughout the night and then went back to sleep from 05:00 to 10:00 (12/23/2020). Woke up symptom free and have remained symptom free.
CHILLS; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient experienced polymyalgia rheumatica (pmr) when treated with varicella zoster vaccine live (oka/merck) for shingles. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 25-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills. This report was non-serious.
Pt. received FLUZONE QUAD vaccine IM 10/30/17. Mother reported pt. to be experiencing a couple of hives, which was normal for pt. Mother called back to office 11/2/17 to report increase hives, face, arms, chest, legs. Which she was treating with oral BENADRYL. Denied any other symptoms. Resolved after 5 days. F/U with mother 11/15/17, no further symptoms to report.
localized redness / small redness at the site injection; which is sore when I press on the site; This case was reported by a consumer and described the occurrence of injection site erythema in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 7th October 2020, the patient received the 1st dose of Shingrix. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced injection site erythema and injection site tenderness. On an unknown date, the outcome of the injection site erythema and injection site tenderness were unknown.   It was unknown if the reporter considered the injection site erythema and injection site tenderness to be related to Shingrix.  Additional information was provided as follows: The age at vaccination was not reported. The age group was selected as adult as per the vaccine indication. The patient received 1st dose of Shingrix and experienced a localized redness about the size of a baseball, which was sore when pressed on the site and also had a small redness at the site injection. The patient was concerned about getting a 2nd dose.
Received my Flu shot as part of the hiring process for a new job.  Approximately 30 mins after the injection I started to experience arm (muscle) pain.  I did not thing much of it until the next day when I could not raise my arm without excruciating pain.  I did talk with my primary care physician about it but of course once you receive the shot there isn't anything you can do about it.  Now, 5 months later I am still having pain and decreased ROM.  I am told that I must receive the flu shot every year for my job but I'm very apprehensive to get another one.
A couple days later I began experiencing a slight sore arm.  Several days later I had a constant headache.  Around January 25 I began experiencing non-stop chest pain and on January 27 woke up with severe pain in my arm. I went to the emergency room and was diagnosed with an NSTEMI.
Redness and swelling greater than baseball size at subcutaneous injection site went large induration at center of injection site on under side of left arm. Developed around 4pm the same date of injection, flu like symptoms (headache, low grade fever, muscle aches, neck ache severe fatigue) had to go to bed at 6pm. Symptoms worsens the next day. Took ADVIL, TYLENOL, BENADRYL and used ice at site. On 24-May-2018, flu like symptoms subsided except headache and site reddness was a little larger on the upper part of the reaction that was till red, warm to touch with induration at center. Seeing Dr. today at 8:30 AM.
Narrative:  Pt has Lt arm-,deltoid, Lt shoulder shooting/sharp pain- after 7 days of injection. Hand- 4 digit numbness everything excluding 5th digit. No visible injection mark- Pt pointed to distal deltoid region, posterior upper arm as location of injection. Injection might have not been given into deltoid but posterior/distal to that location. Labs, X-ray have been ordered- no results yet. Provider prescribed Gabapentin for nerve pain.
Bedridden for 36+ hours. Severe flu like symptoms- fever, chills, weakness, fatigue. Dry mouth. Dry eye. No sense of taste. Still sick as I fill out this report.
Patient states she experienced feelings of her throat closing up, states she took Benadryl and called her Physician and was advised to not receive second moderna injection.
Psoriasis flare ups and psoriatic arthritis flare up. Had zero psoriasis patches on skin for a long time, especially prior to receiving the vaccine.  4-6 weeks after receiving the last dose of the vaccine I noticed more joint pain and the first psoriasis patch showed up.  I?ve continued to get more and more. I currently have about 15 patches since. I have never had that many psoriasis patches appear. The most I have ever had is 3.
The patient received the Pfizer vaccine injection Tuesday November 30th at 1:30pm.  It resulted in significant rash whereas she self administered Benadryl for the symptom at home.   On Thursday December 2nd, the rash had subsided.
The pt experienced a reddened area at the site with some swelling. Was seen in ER and begun on antibiotics. The child was afebrile and appeared well otherwise.
Last injection 1/10/2021 began with SOB in Feb, visited Cardiologist on 3/1/2021 - EKG changes 3/24/2021  Echo cardiogram with decreased EF 4/15/2021 CTA, cardiac, with decreased EF started heart failure Rx beginning of April (coreg & entresto)  4/27/2021 - Consult with cardiologist,  6/4/2021 - MRI @   coming up, June 29th, f/u echo with MD appt,
Fever, upto 101.7, entire body aches. Adverse effects laste for 1 1/2 days. Woke up on morning of 7/2 and felt fine.
Pt has redness and swelling at injection site approximately the size of a hand. Advised patient to take Benadryl as directed and to let us know if the condition worsens or is not resolved within 1 week.
Heart racing a few times that afternoon (approx 2-6 hours post injection), 9 days later hard painful lump at site of injection approx 3 inches diameter. Appeared very quickly, hot to touch, burning pain, movement uncomfortable
Presents to ED the day after 2nd covid vaccine with syncope,general  weakness, nausea, headache, vomiting. Admitted for 2 days for syncope workup. Improved with IV fluids. d/c'd home in stable condition.
MUSCLE PAIN ON RIGHT LEG RADIATING TO BOTH LOWER EXTREMITIES. ABDOMINAL PAIN.
5 days p/flu shot pt devel large hives & itching all over; t102; pt seen @ clinic by MD, crackles lower lobe, CXR done, dx pneumonia; Erythromycin & DPH for hives;
Chest began to feel very tight, breathing became labored within 6 hours of getting the vaccine. I could not sleep the night of the vaccine because lying down on my back or side made the pain/tightness in chest worse. This continued through the next day and night (still could not sleep due to pain and discomfort in chest lying down). The tightness and pain were at the very center of my chest. Breathing hurt, and I felt like I couldn't get enough air even though I was breathing fully. These events are still going on today (7/20/21) 3 days after the vaccine. I had fever and nausea last night, and my chest pain seems to be doing better today but still present.
Body Aches, Soreness at the injection site, low-grade fever (101), fatigue, headache
Information has been received from a licensed practical nurse concerning a 62 year old male patient with no medical history or allergies who on 08-SEP-2009 was vaccinated subcutaneously with a 0.65 ml dose of ZOSTAVAX (Merck) (lot # 663882/0133Y). There was no concomitant medication. On 08-SEP-2009 the patient experienced an allergic reaction after receiving ZOSTAVAX (Merck). Approximately 30 minutes after receiving ZOSTAVAX (Merck), the patient came back into the office complaining of redness on his whole body and difficulty in breathing. The patient also complained of tingling sensation all over the body. The patient was given epinephrine, oxygen, and BENADRYL. The patient was taken to an emergency room and released. Electrocardiogram (EKG) was performed and the outcome was unknown. At the time of report, the patient was recovering. Allergic reaction was considered to be life-threatening and an other important medical event by the physician. A lot check has been initiated. Additional information has been requested.
Doctor office INFLUENZA vaccine. There was a pregnant women who requested to have the flu vaccine in the gluteal muscle. The medical assistant administered the vaccine as the patient requested. The proper steps have been taken to prevent these types of errors in the future.
Slight fever, chills, headache, body aches after second shot. Gone after two days.  Rash in groin area and underarms. Not painful and does not itch, just redness. Noticed on day 3 after second shot.
Information has been received from a health professional concerning a 4 year old female who on 25-JUL-2007 was vaccinated SC on the right thigh with the second dose of varicella virus vaccine live (Oka/Merck) (Lot # 657757/0641U). Concomitant therapy included the fourth dose of an IM administration of diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid (Lot # AC14B046AA) to the right thigh, the fourth dose of a SC administration of poliovirus vaccine (Lot #Z1069) to the left thigh and the second dose of a SC administration of measles-mumps-rubella vaccine (MSD) (Lot# 656038/0204U) to the left thigh. On 27-JUL-2007 the patient experienced right outer thigh with red area at site. The patient's outcome was no reported. Additional information has been requested.
Lt arm red & swollen 12cm x 10cm. Firm swelling. BENADRYL 25mg 1-6hrs #40. Hydrocortisone cream 2.5mg 4x a day PRN.
Booster on Jan 3 Tested Positive for Covid Jan 11 - mild Bad headache Jan 22 Tinnitus started that nigh
Swelling of upper left leg between the knee and groin. Difference in circumfrence is 5 centimeters from right leg.
Pt received first dose at 11am. At 1108am patient reported feeling diaphoretic and shaky. Pt reported she did not eat bksft prior to coming. Blood sugar checked, result 98. Pt remained shaky, moved to private area and resting. Oxygen placed at 2L. Provider assessed patient with vital signs of 158/97, pulse 96, resp 22.  Patient was given juice and crackers. Provider order for infusion of 500ml of normal saline.  Post infusion, patient remained shaky,  Provider order to send to ED for eval. EMS called.
positive COVID-19 test; positive COVID-19 test; This is a spontaneous report from a Pfizer-sponsored program by a contactable consumer (patient).   This female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at single dose on 22Jan2021 for Covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient resulted positive to COVID-19 after vaccination on 28Jan2021 with outcome of unknown. The patient underwent lab tests and procedures which included SARS-CoV-2 test: positive on 28Jan2021.  Information on the lot/batch number has been requested.
Rapid heartbeat, pressure in chest within three hours of vaccine administration. Sleeplessness. Prescribed Inderal for the symptoms, which lasted six weeks. I had blood drawn several times over this period, with elevated thyroid antibodies throughout. The vaccine triggered an immediate autoimmune thyroid response which lasted six weeks.  Once the symptoms subsided I obtained the second vaccine with only normal side effects.
pt recv vax 25JAN98 & pt was subsequently found to be a nonresponder to the vax;
started w/vomiting & diarrhea on 27JAN97;early in the morning woke up from nap around 1PM-started w/a sz;transported to ER fever was 104.9 @ hosp;
Information has been received from a nurse concerning an unknown number of patients of unknown age and gender. The patient's medical history, concurrent condition and concomitant therapy were not reported. On unknown dates, the patients were vaccinated with doses of improperly stored M-M-R II, albumin status rHA, batch # J006136, lot # 0116AE, expiration date 06-JUL-2015 (dose, and route not reported). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
This spontaneous report was received from a medical assistant and refers to the multiple unspecified patients of unknown age and gender. No information regarding the patients' pertinent medical history, drug reactions or allergies and concomitant therapies were reported. On an unknown dates, the unspecified multiple patients were vaccinated with a dose of VAQTA lot number: M039202, expiration date: 11-MAR-2018 (dose and route of administration were not reported). There was no adverse effect reported. Administered doses of vaccines experienced the temperature excursion of 32 to 35 degrees Fahrenheit (35.2 degrees Fahrenheit) for 1 hour and 50 minutes. The previous temperature excursion was reported as 32 to 35 degrees Fahrenheit (35.4 degrees Fahrenheit) for 55 minutes and 47 to 77 degrees Fahrenheit (48.2 degrees Fahrenheit) for 40 minutes. Data logger was involved. This is one of three reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1704USA015099: US-009507513-1704USA011714.
Patient diagnosed by PCP with adverse event of cellulitis and was prescribed antibiotics. Patient got vaccinated 11/21/16 and went to doctor on 11/26/16.
On 5/10/00, infant manifested with fever of 100F X 3 days with no other symptoms during this phase. After the 3rd day, infant developed rash "from head to toe" that lasted for 5 days. Mother of infant contacted MD office and was told no treatment was needed.
On 4/30/2021 I had extreme vision issues I was unable to see I was treated on 5/2/2021 for eye infections placed on 2 different eye drops since the infection returned again. My eyes still didn't get 100% better I visited another eye dr on 7/19/2021 I was diagnosed with extreme eye dryness and writteen a prescription for restasis which I will have to take daily.
pain at the injection site after 1-2 minutes, heaviness on the left arm worsening progressively. Low grade fever at night, headaches, joint pain.
The pt experienced a 1 1/2 - 2 inch area of redness with swelling and an area of hardness at the site of injection.
Pt seen at clinic 6/2/16 for 10:15 am. appt. Vaccines admin. per protocol. 16:30 Mom called reported pt cried most of the afternoon with limited breaks for feeding and approx. 30 min nap. 16:45 pt arrived at clinic, presented fussy, crying, afebrile, localized erythematous reactions bilateral anterior thighs at inj. sites. TYLENOL administered 17:13, cold compresses applied. Pt settled by 17:35. 6/3 pt vst @ 8:30 am. bilateral erythematous reactions completely resolved. Baby calm.
I developed an active case of shingles on my right side back and trunk. Symptoms continued to increase. I was diagnosed by a doctor's appointment on September 29, 2021 and prescribed an antiviral acylovir 800 mg tablet 5 times a day for 7 days.
Myalgia, Fever, chills Per nursing report: "received her influenza and moderna booster on 1/11/22. She called this morning [1/13] reporting that she started experiencing adverse symptoms on 1/12/22 of bodyaches, chills, fever (100.6 to 101.6)."
Itching, hot to touch on left arm with bruise and swelling the size of pt's fist/hand. Worse last night; seems to be getting better.
This spontaneous report was received from a certified medical assistant referring to a patient of unknown age and gender. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications. On an unknown date, the patient was vaccinated with improperly stored doses of GARDASIL 9 lot number N004799 and expiration date of 15-NOV-2019 for prophylaxis (dose and route of administration were not reported) and M-M-R II rHA lot number L040960 with an expiration date of 16-OCT-2017 and lot number M045402 with an expiration date of 14-NOV-2018 for prophylaxis (dose and route of administration were not provided). The vaccine was exposed to a temperature excursion of 47.1°F with a time frame of 30 minutes. There was no previous temperature excursion. A "data logger" was involved. No adverse effects were reported. This is one of the several reports received from the same reporter. Sender's Comments: US-009507513-1710USA006357: US-009507513-1710USA006358: US-009507513-1710USA006359: US-009507513-1710USA006360: US-009507513-1709USA011980: US-009507513-1710USA006362: US-009507513-1710USA006373: US-009507513-1710USA006364: US-009507513-1710USA006365: US-009507513-1710USA006366: US-009507513-1710USA006367: US-009507513-1710USA006368: US-009507513-1710USA006369: US-009507513-1710USA006370: US-009507513-1710USA006371: US-009507513-1710USA006372: US-009507513-1710USA006356: US-009507513-1710USA006355: US-009507513-1710USA006363.
Soreness at injection site for approximately 24 hours post vaccination Mild headache in hours following vaccination, treated with Aleve Nausea and vomiting 24 hours post vaccination, ended by the following day